OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Clinical trials for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS explained in plain language.
Never miss a new study
Get alerted when new OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS trials appear
Sign up with your email to follow new studies for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a simple home workout fight Chemo's numbness and pain?
Symptom relief Not yet recruitingThis study is testing whether a structured home exercise program can reduce nerve pain and numbness caused by common chemotherapy drugs. It will involve 140 patients with colorectal or gynecologic cancers who are starting treatment with oxaliplatin or paclitaxel. Half will follow…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated Mar 23, 2026 15:18 UTC
-
Chemo's hidden handicap: study probes nerve damage that steals grip and life quality
Knowledge-focused Not yet recruitingThis study aims to understand how nerve damage caused by a common colorectal cancer chemotherapy drug affects patients' hand strength, fine motor skills, and quality of life. Researchers will measure grip strength and hand function in 84 patients who have received oxaliplatin. Th…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Sponsor: Fenerbahce University • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC